Clinical and genetic heterogeneity in congenital hyperinsulinism

European Journal of Pediatrics

Volumn 161, Issue 1, 2002, Pages 6-20

  Meissner, Thomas ^a   Mayatepek, Ertan ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Congenital hyperinsulinism; Familial hyperinsulinism; Nesidioblastosis; Persistent hyperinsulinaemic hypoglycaemia of infancy

Indexed keywords

DIAZOXIDE; GLUCAGON; GLUCOKINASE; GLUCOSE; GLUTAMATE DEHYDROGENASE; HYDROCHLOROTHIAZIDE; INSULIN; NIFEDIPINE; OCTREOTIDE; POTASSIUM CHANNEL; SOMATOSTATIN; SULFONYLUREA RECEPTOR;

AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; CLINICAL PRACTICE; ENZYME ACTIVITY; FOLLOW UP; GENE MUTATION; GENETIC HETEROGENEITY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERINSULINISM; HYPOGLYCEMIA; INHERITANCE; INSULIN RELEASE; LABORATORY DIAGNOSIS; PATHOGENESIS; PATIENT CARE; PRIORITY JOURNAL; RADIODIAGNOSIS; RECEPTOR GENE; REGULATORY MECHANISM; REVIEW; TREATMENT OUTCOME;

EID: 0036136040     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310100850     Document Type: Review

References (140)

1. Intra-arterial calcium stimulation test in the investigation of hyperinsulinaemic hypoglycaemia
2. Cloning of the beta cell high-affinity sulfonylurea receptor: A regulator of insulin secretion
3. Properties and functions of ATP-sensitive K-channels
4. Nesidioblastosis of the pancreas: Definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia
5. Plasma proinsulin and C-peptide concentrations in children with hyperinsulinaemic hypoglycaemia
6. Practical management of hyperinsulinism in infancy
7. Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome
8. Diazoxide treatment of idiopathic hypoglycemia of infancy
9. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy
10. Prolonged hyperinsulinism and hypoglycemia in an asphyxiated, small for gestation infant. Case management and literature review
11. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene
12. Cardiac septal hypertrophy in hyperinsulinemic infants
13. Pancreatic venous sampling in infants and children with primary hyperinsulinism
14. The ABCs of ATP-sensitive potassium channels: More pieces of the puzzle
15. Pancreatic exocrine and endocrine function after pancreatectomy for persistent hyperinsulinaemic hypoglycaemia of infancy
16. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy
17. Localization of the source of hyperinsulinism: Percutaneous transhepatic portal and pancreatic vein catheterization with hormone assay
18. Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during B-cell tumorigenesis
19. Association and stoichiometry of K(ATP) channel subunits
20. Familial hypoglycemia precipitated by amino acids
21. Hyperinsulinism in asphyxiated and small-for-dates infants with hypoglycaemia
22. Controversies regarding definition of neonatal hypoglycemia: Suggested operational thresholds
23. Persistent hyperinsulinemic hypoglycemia of infancy: Long-term results
24. Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose
25. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy
26. Clinical features of 52 neonates with hyperinsulinism
27. Hyperinsulinism in children: Diagnosis value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases
28. Pancreatic exocrine and endocrine function after subtotal pancreatectomy for nesidioblastosis
29. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor
30. Treatment of hyperinsulinaemic hypoglycaemia with nifedipine
31. Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism
32. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: Association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11
33. Parental genomic imprinting of the human IGF2 gene
34. Persistent hyperinsulinemic hypoglycemia of infancy ("nesidioblastosis"): Autosomal recessive inheritance in 7 pedigrees
35. Persistent hyperinsulinemic hypoglycemia of infancy: Long-term octreotide treatment without pancreatectomy
36. Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene
37. Familial hyperinsulinism caused by an activating glucokinase mutation
38. Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism
39. Genetics of neonatal hyperinsulinism
40. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations
41. Amino-acid and alphaketoacid induced hyperinsulinism in the leucine-sensitive type of infantile and childhood hypoglycemia
42. Subtotal pancreatectomy in the management of severe persistant idiopathic hypoglycemia in children
43. Reversible hypertrophic cardiomyopathy associated with nesidioblastosis
44. Hypoglycemia
45. Non-invasive continuous glucose monitoring in type 1 diabetic patients with optical glucose sensors
46. Nesidioblastosis: The pathologic basis of persistent hyperinsulinemic hypoglycemia in infants. Morphologic and quantitative analysis of seven cases based on specific immunostaining and electron microscopy
47. Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death
48. Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin
49. Functional hyperactivity of hepatic glutamate dehydrogenase as a cause of the hyperinsulinism/hyperammonemia syndrome: Effect of treatment
50. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1
51. Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome
52. Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor
53. Subunit stoichiometry of the pancreatic beta-cell ATP-sensitive K+ channel
54. Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy
55. Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy
56. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin
57. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy
58. Clinical and histologic indications for extensive pancreatic resection in nesidioblastosis
59. Nesidioblastoma, the islet tumor of the pancreas
60. A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release
61. Zinc glucagon in the management of idiopathic hypoglycemia
62. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: High incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up
63. Ionic control of beta cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade
64. Congenital hyperinsulinism and the surgeon: Lessons learned over 35 years
65. Impaired expression of transcription factor IUF1 in a pancreatic beta-cell line derived from a patient with persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis)
66. Engineering a glucoseresponsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy
67. Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y
68. Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase
69. Persistent hyperinsulinemic hypoglycemia of infancy: Long-term outcome following subtotal pancreatectomy
70. Neontal hypoglycaemia in infants of insulin-dependent diabetic mothers
71. Persistent neonatal hyperinsulinism
72. Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy
73. Complications of diazoxide in the treatment of nesidioblastosis
74. Idiopathic spontaneously occuring hypoglycemia in infants
75. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia
76. Persistent hyperinsulinaemic hypoglycaemia of infancy: Therapy, clinical outcome and mutational analysis
77. Congenital hyperinsulinism: Molecular basis of a heterogeneous disease
78. Exercise induced hypoglycaemic hyperinsulinism
79. Abnormalities of pancreatic islets by targeted expression of a dominant-negative KATP channel
80. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice
81. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis
82. Novel missense mutations in the glutamate dehydrogenase gene in the congenital hyperinsulinism-hyperammonemia syndrome
83. Near-total pancreatectomy in persistent infantile hypoglycemia
84. Hyperinsulinism and Beckwith-Wiedemann syndrome
85. Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews
86. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism
87. Genetic hetrogeneity in familial hyperinsulinism
88. Adenosine diphosphate as an intracellular regulator of insulin secretion
89. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland
90. Pancreatic and extrapancreatic sulfonylurea receptors
91. Hyperinsulinism plus hyperammonemia
92. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulphonylurea receptor causing familial hyperinsulinism
93. Relevance of endocrine pancreas nesidioblastosis to hyperinsulinemic hypoglycemia
94. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: Deficiency of pancreatic D cells or hyperactivity of B cells?
95. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: The pathologist's role
96. Persistent hyperinsulinaemic hypoglycaemia of infancy: A heterogeneous syndrome unrelated to nesidioblastosis
97. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/ SUR2B types of ATP-sensitive potassium channel
98. The molecular basis of persistent hyperinsulinemic hypoglycemia of infancy and its pathologic substrates
99. Adult nesidioblastosis: A case report and review of the literature
100. Hyperinsulinism: Molecular aetiology of focal disease
101. Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome
102. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors
103. Familial nesidioblastosis: Severe neonatal hypoglycemia in two families
104. ATP-sensitive potassium channels: A model of heteromultimeric potassium channel/receptor assemblies
105. Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice
106. Surl knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion
107. Neonatal hyperinsulinemic hypoglycemia: Heterogeneity of the syndrome and keys for differential diagnosis
108. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy
109. Characterization of genes encoding the pancreatic beta-cell ATP-sensitive K+ channel in persistent hyperinsulinemic hypoglycemia of infancy in Japanese patients
110. Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood
111. Hyperinsulinism in infants and children
112. Hyperinsulinism in infancy: Diagnosis by demonstration of abnormal response to fasting hypoglycemia
113. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene
114. Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: Predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene
115. Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes
116. Hyperinsulinism of infancy: The regulated release of insulin by KATP channel-independent pathways
117. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice
118. Genetic analysis of Japanese patients with persistent hypernsulinemic hypoglycemia of infancy: Nucleotide-binding fold-2 mutation impairs cooperative binding of adenine nucleotides to sulfonylurea receptor 1
119. Clinical use of the long acting somatostatin analogue octreotide in pediatrics
120. Changing concepts of islet cell dysplasia in neonatal and infantile hyperinsulinism
121. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy
122. Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy
123. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familal persistent hyperinsulinemic hypoglycemia of infancy
124. Familial and sporadic hyperinsulinism: Histopathologic findings and segregation analysis support a single autosomal recessive disorder
125. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism
126. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: A retrospective review of 77 cases and analysis of efficacy-predicting criteria
127. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia
128. A syndrome of congenital hyperinsulinism and hyperammonemia
129. Morphological changes in pancreatic islets of KATP channel-deficient mice: The involvement of KATP channels in the survival of insulin cells and the maintenance of islet architecture
130. Aetiological factors in benzothiadiazine hyperglycaemia
131. Idiopathic hypoglycaemia in sibs with morphological evidence of nesidioblastosis of the pancreas
132. Nesidioblastosis: Evidence for autosomal recessive inheritance
133. Beta cell nesidioblastosis in idiopathic hypoglycemia of infancy
134. Assay of plasma insulin in human subjects by immunological methods
135. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure
136. A Japanese case of congenital hyperinsulinism with hyperammonemia due to a mutation in glutamate dehydrogenase (GLUD1) gene
137. Hyperinsulinism-hyperammonemia syndrome caused by mutant glutamate dehydrogenase accompanied by novel enzyme kinetics
138. Biochemical evaluation of a patient with a familial form of leucine-sensitive hypoglycemia and concomitant hyperammonemia
139. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels
140. Monoallelic expression of the human H19 gene